Meeting
2011 ASCO Annual Meeting
Adoption of adjuvant chemotherapy (ACT) for non-small cell lung cancer (NSCLC) in the elderly: A population-based outcomes study.
Authors
S. Cuffe
Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
S. Cuffe , C. M. Booth , Y. Peng , G. E. Darling , G. Li , W. Kong , W. J. Mackillop , F. A. Shepherd
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Lung Cancer - Local-regional and Adjuvant Therapy/Small Cell
Track
Lung Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 29: 2011 (suppl; abstr 7012)
Abstract #
7012
Poster Bd #
6
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Low skeletal muscle area and association with toxicity and hospitalization with chemotherapy in advanced non–small cell lung cancer.
First Author: Anurag Saraf
Poster
2014 ASCO Quality Care Symposium
Effectiveness of cisplatin versus carboplatin-based doublet chemotherapy in elderly Medicare patients with advanced non-small cell lung cancer.
First Author: Elizabeth B. Lamont
Poster
2013 ASCO Annual Meeting
Effect of age on impact of adjuvant chemotherapy for resected non-small cell lung cancer.
First Author: Apar Kishor Ganti
Poster
2024 ASCO Breakthrough
Preliminary analysis of PD-1 inhibitors combined with chemotherapy as neoadjuvant therapy for local advanced non-small cell lung cancer (NSCLC).
First Author: Hongru Li